Your browser doesn't support javascript.
loading
Vagus nerve stimulation therapy in people with drug-resistant epilepsy (CORE-VNS): rationale and design of a real-world post-market comprehensive outcomes registry.
Sen, Arjune; Verner, Ryan; Valeriano, James P; Lee, Ricky; Zafar, Muhammad; Thomas, Rhys; Kotulska, Katarzyna; Jespers, Ellen; Dibué, Maxine; Kwan, Patrick.
Affiliation
  • Sen A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, Oxfordshire, UK.
  • Verner R; Clinical and Medical Affairs, LivaNova Plc, London, UK.
  • Valeriano JP; Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
  • Lee R; Department of Neurology, Ascension Medical Group, Wichita, Kansas, USA.
  • Zafar M; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
  • Thomas R; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
  • Kotulska K; Royal Victoria Infirmary, Newcastle upon Tyne, UK.
  • Jespers E; Department of Neurology and Epileptology, Children's Memorial Health Institute, Warszawa, Poland.
  • Dibué M; Clinical and Medical Affairs, LivaNova Plc, London, UK.
  • Kwan P; Clinical and Medical Affairs, LivaNova Plc, London, UK.
BMJ Neurol Open ; 3(2): e000218, 2021.
Article in En | MEDLINE | ID: mdl-35018342
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BMJ Neurol Open Year: 2021 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BMJ Neurol Open Year: 2021 Type: Article Affiliation country: United kingdom